Pathology/Lab Coding Alert

You Be the Coder:

88172, 88333 Bundling Hurdles Abound

Question: I'm concerned about bundling rules for FNA and core biopsy performed together. If our pathologist examines an FNA and performs touch preps on a core biopsy for the same patient on the same day, how should we code the case? Answer: Pathologists sometimes evaluate FNA specimens intraoperatively so the surgeon can use the findings to determine the need for additional aspirations from the same lesion, or for a more complex procedure like a needle-core biopsy. Your stated bundling concern may relate to the fact that the Correct Coding Initiative (CCI) Policy Manual states that you should not report together a fine needle aspiration (FNA) (10021-10022, Fine needle aspirate; ...) and biopsy (such as 19100, Biopsy of breast; percutaneous needle core, not using imaging guidance [separate procedure]) from the same lesion unless one specimen is inadequate for diagnosis. But that restriction primarily constrains the surgeon. Your pathologist must depend on [...]
You’ve reached your limit of free articles. Already a subscriber? Log in.
Not a subscriber? Subscribe today to continue reading this article. Plus, you’ll get:
  • Simple explanations of current healthcare regulations and payer programs
  • Real-world reporting scenarios solved by our expert coders
  • Industry news, such as MAC and RAC activities, the OIG Work Plan, and CERT reports
  • Instant access to every article ever published in your eNewsletter
  • 6 annual AAPC-approved CEUs*
  • The latest updates for CPT®, ICD-10-CM, HCPCS Level II, NCCI edits, modifiers, compliance, technology, practice management, and more
*CEUs available with select eNewsletters.

Other Articles in this issue of

Pathology/Lab Coding Alert

View All